Thyrocare Technologies

725.05
+11.60
(1.63%)
ann
There are 2 new updates from the company16 hours ago
Viewcross
right
Market Cap
3,842.29 Cr
EPS
13.42
PE Ratio
43.11
Dividend Yield
2.52 %
52 Week High
1,055.00
52 Week Low
571.40
PB Ratio
7.74
Debt to Equity
0.06
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,749.70
#1 22,985.22
55.12
#1 2,295.80
11.52
#1 362
19.34
65.72
992.40
10,185.62
72.24
568.60
20.11
120
35.77
50.41
1,665.10
8,538.82
55.41
1,216.80
4.59
129
15.38
55.34
725.05
#4 3,842.29
#5 43.11
#5 581.30
#7 8.63
#4 70
#6 29.25
49.84
822.45
2,655.67
34.25
636.40
25.65
57
49.23
55.39
1,799.95
1,544.84
31.57
86.70
25.47
32
58.82
52.01
263.48
838.14
#1 8.35
1,436.10
35.04
6
-1,081.25
62.82
346.95
246.30
21.91
63.00
#1 248.07
7
133.33
54.47
107.55
74.91
56.49
36.90
6.34
1
0.00
31.07
61.19
62.96
72.89
13.60
-8.11
-3
#1 142.86
29.57
Growth Rate
Revenue Growth
8.63 %
Net Income Growth
7.92 %
Cash Flow Change
29.63 %
ROE
9.57 %
ROCE
10.57 %
EBITDA Margin (Avg.)
5.21 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
56
63
55
67
72
81
74
89
93
92
88
108
99
107
100
108
112
119
107
104
58
158
141
151
175
191
119
133
129
137
131
140
136
151
138
158
161
180
170
Expenses
37
36
35
41
42
64
51
60
53
53
49
60
56
61
61
71
64
64
62
77
48
91
89
95
94
87
81
93
92
103
100
111
100
111
103
121
115
129
124
EBITDA
20
26
20
27
30
17
23
30
39
39
39
48
43
46
39
37
48
55
45
26
9
67
52
55
81
104
38
40
37
33
31
29
36
40
35
37
46
51
46
Operating Profit %
34 %
39 %
36 %
38 %
39 %
18 %
28 %
32 %
39 %
40 %
42 %
39 %
42 %
41 %
37 %
33 %
42 %
45 %
41 %
24 %
15 %
40 %
36 %
35 %
43 %
51 %
31 %
29 %
28 %
23 %
22 %
18 %
26 %
25 %
23 %
22 %
27 %
27 %
25 %
Depreciation
5
4
5
5
4
4
5
5
4
5
5
6
6
7
7
7
7
8
8
9
7
8
8
8
7
8
9
10
9
9
10
11
10
11
14
13
11
13
17
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
-0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
17
25
19
22
26
13
19
25
35
34
34
42
38
39
32
29
40
46
37
18
2
59
44
48
74
95
29
30
28
24
20
17
25
28
20
23
34
37
28
Tax
6
9
8
8
9
11
9
9
13
10
12
17
14
14
12
13
13
11
9
19
2
16
12
10
18
18
7
9
6
8
5
5
8
8
5
6
10
10
9
Net Profit
11
16
11
14
17
1
9
15
22
25
22
25
23
25
20
16
28
35
28
-2
0
43
32
38
56
78
22
21
22
15
15
13
17
20
15
17
24
26
19
EPS in ₹
2.33
3.28
2.13
2.71
3.18
0.22
1.71
2.90
4.10
4.59
4.03
4.68
4.35
4.70
3.81
3.09
5.20
6.73
5.21
-0.30
0.04
8.15
6.13
7.14
10.51
14.70
4.05
4.04
4.11
3.80
2.78
2.36
3.26
3.84
2.78
3.54
4.52
4.99
3.58

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
329
410
438
479
475
471
546
608
633
644
Fixed Assets
196
259
259
299
294
269
253
285
294
306
Current Assets
111
134
150
142
136
152
240
270
273
279
Capital Work in Progress
6
1
17
0
2
5
8
3
2
3
Investments
84
92
104
120
95
90
126
146
144
162
Other Assets
43
58
58
60
84
107
159
174
193
173
Total Liabilities
329
410
438
479
475
471
546
608
633
644
Current Liabilities
7
31
18
20
21
82
95
65
77
91
Non Current Liabilities
10
13
12
15
19
23
23
17
20
26
Total Equity
312
366
408
443
435
367
427
527
535
528
Reserve & Surplus
226
312
354
390
382
314
374
474
463
440
Share Capital
51
54
54
54
53
53
53
53
53
53

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
5
-1
-0
-5
4
5
0
4
-9
Investing Activities
-18
-18
-42
-43
-12
1
-49
-24
-39
-91
Operating Activities
35
68
90
107
100
168
115
113
129
168
Financing Activities
-23
-45
-49
-64
-94
-165
-62
-89
-86
-85

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
66.14 %
66.14 %
71.22 %
71.18 %
71.18 %
71.18 %
71.14 %
71.14 %
71.14 %
71.14 %
71.14 %
71.11 %
71.11 %
71.11 %
71.11 %
71.06 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.46 %
0.00 %
2.90 %
2.49 %
1.93 %
2.77 %
DIIs
7.14 %
6.17 %
6.07 %
6.37 %
6.52 %
6.68 %
8.66 %
8.69 %
8.45 %
13.46 %
13.33 %
13.55 %
14.88 %
14.90 %
14.80 %
14.67 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.01 %
6.32 %
7.60 %
7.44 %
6.65 %
6.71 %
7.28 %
8.07 %
8.38 %
9.42 %
9.66 %
9.15 %
8.48 %
8.66 %
9.78 %
9.16 %
Others
21.71 %
21.37 %
15.11 %
15.01 %
15.66 %
15.43 %
12.91 %
12.10 %
12.03 %
5.97 %
2.42 %
6.19 %
2.63 %
2.84 %
2.38 %
2.33 %
No of Share Holders
0
44,722
53,140
62,936
65,769
66,315
66,431
71,412
74,386
76,292
72,000
68,844
64,823
61,636
59,377
56,666

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 10 10 20 5 25 15 18 18 0.00
Dividend Yield (%) 0.00 1.68 1.87 4.03 0.55 3.22 3.56 3.05 2.65 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation16 hours ago
Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of The Final Dividend If Any For The Financial Year 2024-25.16 hours ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 03, 2025
Integrated Filing (Financial)Feb 03, 2025
Updated Limited Review Report On The Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 03, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Integrated Filing (Financial)Jan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 23, 2025
Appointment of Company Secretary and Compliance OfficerJan 23, 2025
Announcement under Regulation 30 (LODR)-RetirementJan 23, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJan 23, 2025
Financial Results For Quarter And Nine Months Ended December 31 2024Jan 23, 2025
Presentation on Un-audited Financial Results (Standalone and Consolidated) for the Quarter and nine months ended December 31 2024Jan 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 16, 2025
Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2024.Jan 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 09, 2025
Intimation Of Change In Name Of Registrar And Share Transfer Agent (RTA).Jan 01, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 10, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 09, 2024
Disclosure Under Regulation 30 - Equity Infusion In Thyrocare Laboratories (Tanzania) Limited - Joint VentureDec 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 06, 2024
Disclosure under Regulation 30A of LODROct 31, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 23, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 23, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 23, 2024
Financial Results For September 30, 2024Oct 23, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On October 23, 2024Oct 23, 2024
Re-Scheduling Of Invite For Earnings Conference CallOct 23, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 16, 2024
Board Meeting Intimation for Considering And Approving The Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024.Oct 16, 2024
Completion Of Business Transfer Agreement With Vimta Labs LimitedOct 11, 2024
Closure of Trading WindowSep 27, 2024
Announcement under Regulation 30 (LODR)-CessationSep 19, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 30, 2024
Execution Of Business Transfer Agreement With Vimta Labs Limited.Aug 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 23, 2024
Announcement under Regulation 30 (LODR)-CessationAug 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2024
Business Responsibility and Sustainability Reporting (BRSR)Aug 01, 2024

Technical Indicators

RSI(14)
Neutral
49.84
ATR(14)
Less Volatile
27.29
STOCH(9,6)
Neutral
49.96
STOCH RSI(14)
Neutral
70.43
MACD(12,26)
Bullish
1.24
ADX(14)
Weak Trend
17.25
UO(9)
Bearish
52.23
ROC(12)
Downtrend And Accelerating
-2.30
WillR(14)
Neutral
-44.72